Skip to main content
See every side of every news story
Published loading...Updated

Experimental Drug Effectively Treats Alzheimer’s in Preclinical Study

Summary by Sci Tech Daily
NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern University reports that NU-9, an experimental small-molecule drug currently approved by the U.S. Food and Drug Administration (FDA) for clinical trials in treating amyotrophic lateral sclerosis (ALS), also improves neuron health in animal models of Alzheimer’s disease. Both ALS [...]

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Sci Tech Daily broke the news in on Thursday, April 17, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal